ACAD CHMP opinion: Thursday, June 25, 2026
EventCHMP opinion
DateThursday, June 25, 2026
MarketUS listing
SourceEMA CHMP · confidence 90% · primary source ↗
positive opinion · Daybu · INN trofinetide · Daybu is indicated for the treatment of neurobehavioural symptoms of Rett syndrome in adults and paediatric patients aged 5 years and older
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.